Release Date: 26/08/10 10:40 Summary: Announcement of Half Year Results to 30 June 2010 Price Sensitive: No Download Document 46.68KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%